Volume 2010, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426


Post-operative radiotherapy to the breast is a standard treatment for the management of breast cancer. Treatment-related skin toxicity will occur in many patients and usually develops two to three weeks into treatment and may persist for up to four weeks post therapy. Management of acute toxicity remains a challenge for oncology professionals because there is very limited evidence-based research that addresses interventions for the prevention and management of radiation skin damage. Forty breast cancer patients being treated with radiotherapy at Al Amal Hospital were evaluated for the frequency and the severity of acute skin reactions. Clinical skin evaluation was performed by the same Radiation Oncologist during weekly reviews and on the last day of treatment. Normal tissue damage was scored according to the Radiation Therapy Oncology Group side-effect scales. The most frequent acute complications were erythema and dry desquamation, although moist desquamation was a problem in high friction anatomical sites. The reactions were classified as severe (RTOG’2) in only one case. There was remarkable consistency in the assessment and documentation of patient education among nurses following the hospital's standard practice.


Article metrics loading...

Loading full text...

Full text loading...


  1. Porock D, Kristajonson L. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. Eur. J. Cancer Care. 1999; 8:143153.
    [Google Scholar]
  2. Nalor W, Mallett J. Managemen t of acute radiotherapy induced skin reactions: a literature review. Eur. J. Oncology Nursing. 5:4:221233.
    [Google Scholar]
  3. Bolderston Amanda, et al., The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer. 2006; 14::802817.
    [Google Scholar]
  4. Korinko Amy, et al., Main taining skin in tegrity during radiation therapy. American Journal of Nursing. February 1997; 97:2:4044.
    [Google Scholar]
  5. Burch SE. Measuremen t of 6-MVX-ray surface dose when topical agents are applied prior to external beam irradiation. Int J Radiat Oncol Biol Phys. 38::447451.
    [Google Scholar]
  6. Pommier P, et al., Phase III randomized trial of calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004; 22::14471453.
    [Google Scholar]
  • Article Type: Other
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error